Sai Life Sciences Limited (NSE: SAILIFE) reports Q2 FY27 revenue growth of 23% YoY, maintaining strong EBITDA margin.
AstraZeneca Pharma India Limited reports 30% growth in Q2 FY26-27 with INR 7,291 Mn revenue, driven by strong commercial performance.
Fortis Healthcare Limited (FORTIS) reports consolidated revenues of INR 2,735 Cr for Q2 FY27, up 17.3%, with a PAT margin of 11.7%.
GPT Healthcare Limited (NSE: GPTHEALTH) reports a 16.5% YoY increase in total income for H1 FY27, driven by strong operational metrics.
Windlas Biotech Limited (WINDLAS) reports H1 & Q2 FY27 results with record revenue of Rs. 512 crores, 18% YoY growth, and strong profitability metrics.
Windlas Biotech Limited (WINDLAS) reports a 19% YoY revenue growth to Rs. 264 crore in Q2 FY27, driven by strong performance across all business verticals.
Max India Limited (MAXIND) announces the appointment of Dr Rachit Gulati as PMR Specialist at Antara Care Home, enhancing post-operative and high-dependency.
Fermenta Biotech Limited (FERMENTA) reports H1FY27 consolidated revenue of INR 261.9 crore, down 7% YoY.
Shilpa Medicare Limited (SHILPAMED) reports record earnings for 2Q & 1HFY27, with revenue and EBITDA hitting new highs.
Hester Biosciences Limited (HESTERBIO) announces securing a USD 1 million unsecured loan for business and general corporate purposes.